Back to RAYMOND JAMES FINANCIAL INC RAYMOND JAMES FINANCIAL INC

BCLIBCLI
2 quarters

Position history for RAYMOND JAMES FINANCIAL INCRAYMOND JAMES FINANCIAL INC's holdings in BrainStorm Cell Therapeutics In

RAYMOND JAMES FINANCIAL INC previously held 0 shares of BCLI (BrainStorm Cell Therapeutics In), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$5,777

Total Shares Change

-5,158

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$0.70
0
2025-Q2
New
5,158
-
$5,7770.0%$1.06
24

Other major holders of BCLI: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used